Your Cart ( 1 Item )

• A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis
  August 2018 | Volume 17 | Issue 8 | Original Article | 888 | Copyright © August 2018
  Boni E. Elewski MD,^a Leon H. Kircik MD,^b Nathan Stasko PhD,^c Emily De Leon MSCR,^c Carolyn Enloe MPH,^c Todd Durham PhD,^c Tomoko Maeda-Chubachi MD^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs